Source: International Congress 2015 – Notable abstracts in COPD: variety
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marc Miravitlles (Barcelona, Spain), Marc Miravitlles, Esther Garcia Gil, Ferran Chuecos, Rosa Lamarca. Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients. Eur Respir J 2015; 46: Suppl. 59, 1968

Member's Comments

No comment yet.

Related content which might interest you: QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Repercussion of cough in sleep quality in COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Effect of glycopyrronium vs tiotropium on pulmonary function and morning symptoms in patients with moderate-to-severe COPD: The SPRING study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Do patients with asthma cough more frequently at night during impedance/pH monitoring than other patients with chronic cough? Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Once-daily QVA149 improves symptom scores in patients with COPD Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Assessing COPD profiles and outcomes by dyspnoea severity Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Are COPD patients with chronic dyspnea and attending pulmonary rehabilitation treated with dual bronchodilatation or not? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014 PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 COPD patients may suffer from frequent exacerbations but mostly do not - Subpopulations of a real life survey in more than 1.700 patients Source: International Congress 2014 – COPD exacerbations Year: 2014 Once-daily glycopyrronium improves lung function and reduces exacerbations in severe-to-very severe COPD patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Impact of nighttime and early morning symptoms on HRQoL and work productivity of COPD patients Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Impact of pulmonary rehabilitation on cough and sputum symptom perception in patients with COPD Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015